Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Signaling by ALK fusions and activated point mutants | Homo sapiens |
Signaling by CSF1 (M-CSF) in myeloid cells | Homo sapiens |
Signaling by LTK | Homo sapiens |
Signaling by LTK in cancer | Homo sapiens |
Signaling by PDGFRA extracellular domain mutants | Homo sapiens |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | Homo sapiens |
Synthesis of PIPs at the plasma membrane | Homo sapiens |
Tie2 Signaling | Homo sapiens |
VEGFA-VEGFR2 Pathway | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110115 | autoimmune lymphoproliferative syndrome type 2A | |
DOID:0110116 | autoimmune lymphoproliferative syndrome type 2B | |
DOID:0110119 | autoimmune lymphoproliferative syndrome type 3 | |
DOID:0110235 | cataract 2 multiple types | |
DOID:0110248 | cataract 30 | |
DOID:0110423 | dilated cardiomyopathy 1C | |
DOID:0110424 | dilated cardiomyopathy 1CC | |
DOID:0110425 | dilated cardiomyopathy 1A | |
DOID:0110426 | dilated cardiomyopathy 1D | |
DOID:0110427 | dilated cardiomyopathy 1V |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024